295 related articles for article (PubMed ID: 29966439)
1. Five-year observation of the relationship between body mass index and glycated hemoglobin in children with Type 1 diabetes mellitus.
Kadłubiska A; Małachowska B; Noiszewska K; Fendler W; Głowińska-Olszewska B; Bossowski A; Łuczyński W
Scand J Clin Lab Invest; 2018 Sep; 78(5):398-406. PubMed ID: 29966439
[TBL] [Abstract][Full Text] [Related]
2. Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.
Mortensen HB; Robertson KJ; Aanstoot HJ; Danne T; Holl RW; Hougaard P; Atchison JA; Chiarelli F; Daneman D; Dinesen B; Dorchy H; Garandeau P; Greene S; Hoey H; Kaprio EA; Kocova M; Martul P; Matsuura N; Schoenle EJ; Søvik O; Swift PG; Tsou RM; Vanelli M; Aman J
Diabet Med; 1998 Sep; 15(9):752-9. PubMed ID: 9737804
[TBL] [Abstract][Full Text] [Related]
3. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
[TBL] [Abstract][Full Text] [Related]
4. Body composition in children with type 1 diabetes in the first year after diagnosis: relationship to glycaemic control and cardiovascular risk.
Davis NL; Bursell JD; Evans WD; Warner JT; Gregory JW
Arch Dis Child; 2012 Apr; 97(4):312-5. PubMed ID: 22294667
[TBL] [Abstract][Full Text] [Related]
5. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.
Szadkowska A; Michalak A; Chylińska-Frątczak A; Baranowska-Jaźwiecka A; Koptas M; Pietrzak I; Hogendorf A; Zmysłowska A; Młynarski W; Mianowska B
J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1073-1079. PubMed ID: 30240358
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional and longitudinal relationships of body mass index with glycemic control in children and adolescents with type 1 diabetes mellitus.
Nansel TR; Lipsky LM; Iannotti RJ
Diabetes Res Clin Pract; 2013 Apr; 100(1):126-32. PubMed ID: 23339757
[TBL] [Abstract][Full Text] [Related]
7. Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes.
Yamada E; Okada S; Nakajima Y; Bastie C; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
J Diabetes; 2018 Feb; 10(2):140-147. PubMed ID: 28544548
[TBL] [Abstract][Full Text] [Related]
8. Three-Variate Longitudinal Patterns of Metabolic Control, Body Mass Index, and Insulin Dose during Puberty in a Type 1 Diabetes Cohort: A Group-Based Multitrajectory Analysis.
Schwandt A; Kuss O; Dunstheimer D; Karges B; Kapellen T; Meissner T; Witsch M; Flury M; Straubinger S; Holl RW;
J Pediatr; 2020 Mar; 218():64-71.e3. PubMed ID: 31952845
[TBL] [Abstract][Full Text] [Related]
9. Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.
Rasmussen VF; Vestergaard ET; Schwandt A; Beltrand J; Rami-Merhar B; O'Riordan SMP; Jarosz-Chobot P; Castro-Correia C; Gevers EF; Birkebæk NH
J Pediatr; 2019 Dec; 215():216-222.e1. PubMed ID: 31345576
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes.
Fujishima Y; Maeda N; Inoue K; Kashine S; Nishizawa H; Hirata A; Kozawa J; Yasuda T; Okita K; Imagawa A; Funahashi T; Shimomura I
Cardiovasc Diabetol; 2012 Sep; 11():107. PubMed ID: 22973968
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of newly diagnosed adults with type 1 diabetes in the UK and evolution of glycaemic control, body mass index and Charlson comorbidity index over the first 5 years after diagnosis.
Ramtoola S; Nyeland ME; Jacobsen J; Ploug UJ; Kragh N; Zimmermann E
Prim Care Diabetes; 2020 Aug; 14(4):349-355. PubMed ID: 31668975
[TBL] [Abstract][Full Text] [Related]
12. Patterns in Body Mass Index Changes in Children after Type 1 Diabetes Mellitus Diagnosis.
Tenenbaum Weiss Y; Friger M; Haim A; Hershkovitz E
Isr Med Assoc J; 2023 Feb; 25(2):137-142. PubMed ID: 36841984
[TBL] [Abstract][Full Text] [Related]
13. The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour.
de Boer SA; Lefrandt JD; Petersen JF; Boersma HH; Mulder DJ; Hoogenberg K
Int J Clin Pharm; 2016 Feb; 38(1):144-51. PubMed ID: 26597956
[TBL] [Abstract][Full Text] [Related]
14. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
[TBL] [Abstract][Full Text] [Related]
15. Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial.
Yang D; Yan J; Deng H; Yang X; Luo S; Zheng X; Lv J; Liang W; Hong M; Wu Z; Yao B; Weng J; Xu W
J Diabetes Res; 2020; 2020():7419345. PubMed ID: 33457425
[TBL] [Abstract][Full Text] [Related]
16. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control.
Soliman AT; Omar M; Assem HM; Nasr IS; Rizk MM; El Matary W; El Alaily RK
Metabolism; 2002 Mar; 51(3):292-6. PubMed ID: 11887162
[TBL] [Abstract][Full Text] [Related]
17. Development and linear growth in diabetic children receiving insulin pigment.
Mao L; Lu W; Ji F; Lv S
J Pediatr Endocrinol Metab; 2011; 24(7-8):433-6. PubMed ID: 21932577
[TBL] [Abstract][Full Text] [Related]
18. Three-variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetes.
Tauschmann M; Schwandt A; Prinz N; Becker M; Biester T; Hess M; Holder M; Karges B; Näke A; Kuss O; von Sengbusch S; Holl RW;
Pediatr Diabetes; 2022 May; 23(3):330-340. PubMed ID: 35084795
[TBL] [Abstract][Full Text] [Related]
19. Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes.
Hathout EH; Fujishige L; Geach J; Ischandar M; Maruo S; Mace JW
Diabetes Technol Ther; 2003; 5(5):801-6. PubMed ID: 14633345
[TBL] [Abstract][Full Text] [Related]
20. Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes.
Hathout EH; McClintock T; Sharkey J; Kytsenko D; Hartwick N; Hadley-Scofield M; Torgeson S; Mace JW
Diabetes Technol Ther; 2003; 5(2):175-81. PubMed ID: 12871607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
